Browse by category

Bariatric and metabolic surgery (BMS) is safe and induces substantial weight loss that reduces the need for T2DM medications, according...

The Diabetes Remission Index (DRI) and Weight Loss-Adjusted Diabetes Remission Index (W-DRI) models – used to assess type 2 diabetes...

Adolescents who perceive themselves as overweight are three times more likely to consider committing self-harm compared to those who do...

Response Pharmaceuticals has completed enrolment in a Phase 2 trial evaluating the company’s drug candidate, RDX-002, for post-GLP-1...

Palatin Technologies has completed its Phase 2 BMT-801 clinical study of the co-administration of MC4R bremelanotide + GLP-1/GIP...

Wave Life Sciences has announced clinical trial application (CTA) approval and initiation of the Phase 1 INLIGHT clinical trial of...

The American Diabetes Association (ADA) has announced a new suite of resources to support improved care for those living with obesity....

Despite the improvements in physical and mental health after bariatric and metabolic (BMS) procedures there is a possibility of a...

Researchers from Peking University, China, have revealed a sharp rise in the burden of early-onset type 2 diabetes mellitus (T2DM) among...

Rani Therapeutics has revealed new pharmacokinetic (PK) and pharmacodynamic (PD) data from a preclinical study evaluating the oral...